Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/CGON/Capital expenditures

CG Oncology, Inc. (CGON) Capital expenditures 2024–2025

CG Oncology, Inc. (CGON) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$134,000FY2025 · since FY2024: $234,000 → $134,000
2425
Fiscal yearValueYoY
FY2025$134,000-42.7%
FY2024$234,000—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More CGON financial trends

CGON RevenueCGON Net incomeCGON Net marginCGON Gross profitCGON Gross marginCGON Operating incomeCGON Operating marginCGON Operating cash flowCGON Free cash flowCGON Return on equityCGON Stock buybacksCGON Dividends paidCGON Total assetsCGON Total liabilitiesCGON Shareholders’ equityCGON overview →